Citigroup
BNTX icon

Citigroup’s BioNTech BNTX Stock Holding History

Citigroup’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.21M Sell
24,900
-100
-0.4% -$10.3K ﹤0.01% 2608
2025
Q4 		$2.38M Hold
25,000
– – ﹤0.01% 2543
2025
Q3 		$2.47M Buy
+25,000
New +$2.67M ﹤0.01% 2505
2025
Q2 		– Sell
-24,700
Closed -$2.25M – 5662
2025
Q1 		$2.25M Sell
24,700
-23,100
-48% -$2.59M ﹤0.01% 2589
2024
Q4 		$5.45M Buy
47,800
+24,500
+105% +$2.8M ﹤0.01% 1871
2024
Q3 		$2.77M Sell
23,300
-1,600
-6% -$147K ﹤0.01% 2387
2024
Q2 		$2M Buy
+24,900
New +$2.28M ﹤0.01% 2353
2024
Q1 		– Sell
-37,200
Closed -$3.93M – 5642
2023
Q4 		$3.93M Buy
37,200
+20,200
+119% +$2.04M ﹤0.01% 1754
2023
Q3 		$1.85M Hold
17,000
– – ﹤0.01% 2051
2023
Q2 		$1.83M Buy
17,000
+5,000
+42% +$562K ﹤0.01% 2300
2023
Q1 		$1.49M Sell
12,000
-148,500
-93% -$20.4M ﹤0.01% 2222
2022
Q4 		$24.1M Hold
160,500
– – 0.02% 716
2022
Q3 		$21.6M Sell
160,500
-69,700
-30% -$10.7M 0.02% 748
2022
Q2 		$34.3M Sell
230,200
-166,000
-42% -$25.4M 0.03% 540
2022
Q1 		$67.6M Sell
396,200
-38,700
-9% -$6.5M 0.04% 386
2021
Q4 		$112M Buy
434,900
+128,500
+42% +$35.2M 0.06% 284
2021
Q3 		$83.6M Sell
306,400
-26,500
-8% -$8.42M 0.05% 341
2021
Q2 		$74.5M Sell
332,900
-53,200
-14% -$10M 0.04% 392
2021
Q1 		$42.2M Sell
386,100
-355,300
-48% -$37.7M 0.03% 572
2020
Q4 		$60.4M Buy
+741,400
New +$72.8M 0.04% 452

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup's BNTX Position: Q1 2026 in Review

Citigroup increased its BioNTech (BNTX) stake by 21% in Q1 2026, buying an estimated $5.56M and bringing the position to 310,366 shares worth $27.6M. The position accounts for 0.01% of the portfolio, ranked #907.

Citigroup first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $45.1M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Citigroup held 310,366 shares of BioNTech worth $27.6M as of Q1 2026.
  • Citigroup bought 54,141 BioNTech shares in Q1 2026, an estimated $5.56M.
  • BioNTech made up 0.01% of Citigroup's portfolio in Q1 2026, its #907 holding.
  • Citigroup first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • Citigroup's BioNTech position peaked at $45.1M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.